An investment for a healthier tomorrow
Sign up for email updates to keep on top of Medicines Australia developments.
If you would like a transcript for courses completed prior to 2012, please complete the online enquiry form.
#ICYMI PAIG member representative Fiona Sheppard talked all things PAIG at the Mercer Life Sciences Industry Confer… https://t.co/4XOlGxFD02
Proposed Changes to Research and Development Tax Incentive will discourage investment and undermine innovation https://t.co/Uwy07pwplo
Great insight by Pharmaceutical Benefits Advisory Committee member Michelle Burke discussing benefits of gene thera… https://t.co/n80iHyda5Y
The @UN International Day for Tolerance was celebrated on 16 Nov but the importance of #acceptance & #diversity sho… https://t.co/NSxNA3Cm4p
#ICYMI the @FinancialReview discussed #ageism and the lack of organisational recognition older Australians receive.… https://t.co/xEINPsV2Gy
RT @Painaustralia: We @Painaustralia are proud to partner with @ArthritisAust & others including our members @MS_Australia on this project.…
MA calls for novel evaluation systems that capture the value of personalised therapies in our sub to the National A… https://t.co/KzXwFuSZAo
Is backlash good for #inclusion? We heard many insights on resistance to #equality via @DivCouncilAus’… https://t.co/VWgum62Yo0
RT @MTPConnect_AUS: Our Managing Director & CEO @DrDanGrant at @AusBiotech #AusBio19 - “if we get this right, Australia’s part in the globa…
RT @AusBiotech: Paul Cross asks our panelists about the potential of gene therapies, with Prof Alan Trounson, @cartherics , @MonashUni, Dr…
RT @DivCouncilAus: The verdict is in. The audience attending tonight's #DCADebate sponsored by #MLCLifeInsurance found 69% to 31% for the A…
RT @program_bridge: The Bridge Consortium overview - our partners who make this program so vital! @Amgen @AbbVie_AU @CSL @Macquarie…
Innovation is happening in our universities and research institutions, these folks are doing it and they want to pa… https://t.co/G045ZRpFrb
You don't have a product unless you've got the intellectual property. Bill Ketelbey, Actinogen Medical, shares a po… https://t.co/Q9ibplXYHb
RT @program_bridge: Thanks to @MedicinesAus for your support and involvement in the #BridgeProgram19! https://t.co/uyebEc1zkA
From bench to biotech! Dr Anna Lavelle, Chair of Medicines Australia, talks about transforming thought to pharmaceu… https://t.co/fVgwLrFgQe
